Physician profile
Kenneth A Jaffe
NPI 1720005812
$1,664.50
in general payments reported to CMS, 2019-2025
21 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $633 · 2021: $65.97 · 2022: $283 · 2023: $249 · 2024: $50.30 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $575.38 | 2020 | |
| Osteoremedies, LLC | $166.12 | 2025 | Blastx, Xperience |
| Orthofix Medical, INC. | $131.36 | 2022-2025 | Cervical-Stim |
| Depuy Synthes Sales INC. | $125.92 | 2022-2025 | Orthovisc, Monovisc |
| Sanara Medtech INC. | $111.97 | 2023 | Celleraterx |
| Flower Orthopedics Coporation | $108.50 | 2022 | |
| Boston Scientific Corporation | $90.78 | 2019-2023 | Spectra Wavewriter |
| Bioventus LLC | $80.25 | 2019-2025 | Exogen Ultrasound Bone Healing System, Bonescalpel & Sonicone (O.R.) |
| Stryker Corporation | $75.23 | 2023 | Mako |
| Ferring Pharmaceuticals INC. | $67.16 | 2019-2020 | |
| Zyla Life Sciences, INC. | $28.92 | 2019 | |
| Si-Bone, INC. | $28.27 | 2020 | |
| Daiichi Sankyo INC. | $19.62 | 2019 | |
| Baudax Bio INC. | $18.95 | 2021 | |
| Pfizer INC. | $13.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.64 | 2019 | |
| Smith+Nephew, INC. | $11.16 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.